Professional Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 26-12-2024
- Paid Up Capital ₹ 4.89 M
as on 26-12-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
as on 26-12-2024
- Revenue -26.90%
(FY 2023)
- Profit 46.02%
(FY 2023)
- Ebitda 132.40%
(FY 2023)
- Net Worth -36.20%
(FY 2023)
- Total Assets -5.04%
(FY 2023)
About Professional Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.89 M.
The company currently has active open charges totaling ₹3.50 M.
Aakanksha Singhal and Anita Singhal serve as directors at the Company.
- CIN/LLPIN
U99999DL1996PTC078971
- Company No.
078971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Professional Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aakanksha Singhal  | Director | 12-May-2018 | Current |
| Anita Singhal | Director | 18-Apr-2018 | Current |
Financial Performance of Professional Biotech.
Professional Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.9% decrease. The company also saw a substantial improvement in profitability, with a 46.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Professional Biotech?
Unlock access to Professional Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genome Diagnostics Private LimitedActive 21 years 1 monthAakanksha Singhal and Anita Singhal are mutual person
Real Time Instrumentation Private LimitedActive 21 years 3 monthsAakanksha Singhal and Anita Singhal are mutual person
Sequence Referral Laboratories Private LimitedActive 14 years 5 monthsAakanksha Singhal and Anita Singhal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 13 Nov 2009 | ₹3.50 M | Open |
How Many Employees Work at Professional Biotech?
Professional Biotech has a workforce of 3 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Professional Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Professional Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
